AMN Stock News Today | Earnings, Events & Price Alerts
This page provides a collection of recent news and events related to AMN Healthcare Services, including updates on its stock performance and financial reports. Notable news includes Marsh's acquisition of AltamarCAM boosting stock price, AMN Healthcare reporting strong Q4 2025 earnings, and plans for EBITDA margin expansion. The events section highlights a retreat in major indices with utilities shining, alongside specific company earnings reports causing stock movements.
Do options traders know something about AMN Healthcare stock we don't?
This article from MSN is incomplete. It provides a title suggesting a discussion about options trading activity in AMN Healthcare stock but contains no actual content to elaborate on this.
AMN Healthcare Services (NYSE:AMN) Trading Down 6% - Should You Sell?
AMN Healthcare Services (NYSE:AMN) experienced a 6% drop in its stock price with significantly lower trading volume, closing at $17.4550. While analysts have a "Hold" consensus rating and an average price target of $22.64, the company's latest earnings matched EPS expectations but showed a negative net margin and PE, raising profitability concerns. Institutional investors have notably adjusted their positions, with hedge funds owning 99.23% of the stock.
Are Options Traders Aware of Insights on AMN Healthcare Stock That We Might Be Missing?
Options traders are showing significant interest in AMN Healthcare Services, Inc. (AMN), indicated by exceptionally high implied volatility for an April 17, 2026 $12.50 Call option. This elevated implied volatility suggests market expectations of substantial future price movements for AMN stock. Despite this, analysts currently rate AMN Healthcare as a Zacks Rank #3 (Hold), with recent earnings forecasts for the current quarter having been lowered.
Teladoc Health Appoints Susan Salka, Experienced Healthcare Executive, to Its Board of Directors
Teladoc Health has appointed Susan Salka, former president and CEO of AMN Healthcare Services, to its board of directors. Salka brings extensive leadership and governance experience in the healthcare sector, having grown AMN Healthcare to over $5 billion in revenue. She will serve on the audit and compensation committees, contributing her insights to Teladoc Health's goal of transforming care delivery and driving health outcomes.
Thompson Investment Management Inc. Acquires 86,579 Shares of AMN Healthcare Services Inc $AMN
Thompson Investment Management Inc. increased its stake in AMN Healthcare Services Inc. by 24.3%, acquiring an additional 86,579 shares and bringing its total holdings to 443,113 shares valued at approximately $6.98 million. Analyst sentiment for AMN Healthcare is mixed, with an average "Hold" rating and a target price of $22.64. Despite reporting in-line EPS and exceeding revenue estimates for the first quarter, the company currently trades with a negative P/E ratio and negative net margin.
AMN Healthcare Services Inc (NYSE:AMN) Sees Large Growth in Short Interest
AMN Healthcare Services Inc (NYSE:AMN) experienced a significant 29.5% increase in short interest during March, reaching 2,812,579 shares and indicating increased bearish sentiment. Despite this, the company met EPS estimates and surpassed revenue expectations in its latest quarterly earnings report. Analysts currently hold a consensus "Hold" rating for the stock with an average target price of $22.64.
Trading Systems Reacting to (AMN) Volatility
This article analyzes the volatility of Amn Healthcare Services Inc (NYSE: AMN) using AI models, highlighting a discrepancy between strong near-term sentiment and persistent mid/long-term weakness. It provides three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis and support/resistance levels. The piece emphasizes the exceptional risk-reward setup targeting a 17.6% gain versus a 0.3% risk.
Vanguard amends 13G/A, reports 0 shares in AMN (NYSE: AMN)
The Vanguard Group has filed an amendment to its Schedule 13G/A, indicating that it no longer beneficially owns any shares (0%) in AMN Healthcare Services Inc. This change is due to an internal realignment effective January 12, 2026, where certain Vanguard subsidiaries will now report their holdings separately, in accordance with SEC Release No. 34-39538.
3 Reasons AMN is Risky and 1 Stock to Buy Instead
This article identifies three reasons why AMN Healthcare Services is considered a risky investment: disappointing long-term revenue growth, declining earnings per share (EPS), and a decrease in Return on Invested Capital (ROIC), indicating less profitable new investments. The author suggests avoiding AMN despite its seemingly cheap valuation and instead recommends looking into unspecified "superior stocks" and a "fast-growing restaurant franchise," as well as highlighting a system for identifying high-quality stocks.
3 Reasons AMN is Risky and 1 Stock to Buy Instead
This article argues that AMN Healthcare Services (AMN) is a risky investment due to disappointing long-term revenue growth, declining earnings per share, and a decreasing return on invested capital. While AMN appears optically cheap, its shaky fundamentals suggest significant potential downside. The author recommends exploring other superior stock opportunities, specifically highlighting the "Amazon and PayPal of Latin America" and six other quality stocks identified by an AI system.
Zacks Research Issues Pessimistic Forecast for AMN Earnings
Zacks Research has lowered its Q4 2027 earnings per share estimate for AMN Healthcare Services (NYSE:AMN) to ($0.10) from ($0.09) and maintained a "Hold" rating. Despite this pessimistic forecast, AMN recently reported Q4 earnings of $0.22 per share, matching consensus estimates, and revenue of $748.23 million, exceeding expectations. The stock currently carries a consensus "Hold" rating with an average target price of $22.64.
If You Invested $1,000 in Amn Healthcare (AMN)
This article analyzes the historical performance of a hypothetical $1,000 investment in Amn Healthcare (AMN) over different periods, detailing its returns and comparing them to the S&P 500. It also provides an overview of Amn Healthcare Services, Inc., describing its business segments, services, and strategic approach to healthcare workforce solutions. The company's financials, operating performance, and regulatory disclosures are outlined for investor reference.
Here’s Why Keeping AMN HealthCare Stock in Your Portfolio Makes Sense
AMN Healthcare Services, Inc. is poised for future growth driven by its Managed Services Program, increasing demand for labor disruption services, and strategic investments in technology and AI. Despite facing challenges such as fluctuating demand post-public health events, pricing pressures from industry consolidation, and intense competition, the company is expected to see a significant increase in earnings by 2026. Its strong earnings performance has consistently surpassed Zacks Consensus Estimates, making it a compelling stock in the healthcare sector.
Here’s Why Keeping AMN HealthCare Stock in Your Portfolio Makes Sense
AMN Healthcare Services, Inc. is poised for future growth driven by its Managed Services Program, increasing demand for labor disruption solutions, and strategic investments in technology and AI, despite recent stock declines and industry challenges. The company has consistently surpassed earnings estimates and expects significant growth in profits and revenue for 2026, making it a compelling stock for investors. However, it faces headwinds from public health event impacts, shifting industry dynamics, and healthcare consolidation pressures.
Here's Why You Should Retain AMN HealthCare Stock in Your Portfolio
AMN Healthcare is expected to grow in the coming quarters due to its broad services, strong Managed Services Program (MSP) momentum, rising labor disruption demand, and investments in technology and AI. The company projects 44.1% earnings growth for 2026 and has surpassed Zacks Consensus Estimates in the last four quarters. Despite potential downsides like demand volatility from public health crises, changing marketplace conditions, and healthcare consolidation, AMN's strategic initiatives and robust demand drivers position it favorably for sustained growth, making it a stock to retain.
What is Zacks Research's Forecast for AMN Q1 Earnings?
Zacks Research has updated its Q1 2027 EPS estimate for AMN Healthcare Services to $1.45, maintaining a "Hold" rating on the stock, while also projecting a FY2028 EPS of $1.48. The company's stock currently holds an average "Hold" rating from analysts with a consensus target price of $22.64, trading around $18.26. In the last reported quarter, AMN met EPS expectations at $0.22 and exceeded revenue expectations at $748.2 million, despite a negative net margin.
Should you buy AMN Healthcare Services (AMN) after golden cross?
The article discusses the potential investment opportunity in AMN Healthcare Services (AMN) following a "golden cross" technical indicator. It likely delves into what a golden cross signifies and how it might impact the stock's future performance, helping investors decide whether to buy.
1 Healthcare Stock with Exciting Potential and 2 We Avoid
This article analyzes the healthcare sector, recommending one stock with strong potential and advising against two others. Insulet (PODD) is highlighted as a compelling buy due to its revenue growth, expanding free cash flow, and rising returns on capital. Conversely, AMN Healthcare Services (AMN) and Quest Diagnostics (DGX) are identified as stocks to avoid, citing concerns such as declining EPS, shrinking returns, and lagging sales growth.
AMN Healthcare Forms Golden Cross, Signaling Potential Bullish Breakout
AMN Healthcare Services, Inc. has formed a "Golden Cross," where its short-term moving average crossed above its long-term moving average, suggesting a potential bullish trend despite significant past declines. While the company's one-year performance shows a 30.14% decline, and longer-term performance is concerning, technical indicators like MACD and KST are mildly bullish. Investors are now watching how this Golden Cross will impact future trading activity and market perception.
Lighthouse Investment Partners LLC Raises Position in AMN Healthcare Services Inc $AMN
Lighthouse Investment Partners LLC significantly increased its stake in AMN Healthcare Services Inc. by 1,557.4% in the third quarter, bringing its total holdings to 262,857 shares worth $5.09 million. Other institutional investors like Vanguard Group Inc., Bank of America Corp DE, Geode Capital Management LLC, Tributary Capital Management LLC, and Allianz Asset Management GmbH also adjusted their positions in the company, which has a high institutional ownership of 99.23%. AMN Healthcare recently reported mixed financial results with revenue above estimates and EPS in line, but operates with a negative net margin, and analysts currently rate the stock as a "Hold" with an average target price of $22.64.
How Amn Healthcare Services Inc (AMN) Affects Rotational Strategy Timing
This article analyzes Amn Healthcare Services Inc (AMN) using AI models to suggest trading strategies. It highlights a near-term weak sentiment, a mid-channel oscillation pattern, and an exceptional risk-reward setup. The analysis provides different strategies tailored to various risk profiles, including position trading, momentum breakout, and risk hedging.
Short Interest in AMN Healthcare Services Inc (NYSE:AMN) Grows By 18.6%
Short interest for AMN Healthcare Services Inc. (NYSE:AMN) rose by 18.6% in February, reaching 2,171,679 shares, which represents 5.7% of the stock sold short. Despite reporting earnings per share that met estimates and revenues exceeding expectations, the company currently has a negative net margin of -3.51%. Institutional investors hold approximately 99.23% of the company's stock, and analysts maintain a "Hold" rating with an average target price of $22.64.
AMN Healthcare Services Inc $AMN Shares Purchased by Algert Global LLC
Algert Global LLC increased its stake in AMN Healthcare Services Inc. (NYSE:AMN) by 10.5% in the third quarter, now owning 1.50% of the company's stock valued at $11.16 million. Other institutional investors also adjusted their positions in AMN Healthcare, which saw its stock price down 2.6% recently. Analysts have issued mixed sentiment with some raising price targets due to positive earnings guidance for FY2026, while others signal potential underperformance in 2027.
Zacks Research Issues Optimistic Outlook for AMN Earnings
Zacks Research has significantly raised its Q1 2026 EPS estimate for AMN Healthcare Services to $1.70 from $0.06, and its FY2026 estimate to $2.17, indicating a much stronger near-term earnings outlook while maintaining a "Hold" rating. However, the report also cut several Q2, Q3 and Q4 2027 estimates, including some turning negative, suggesting increased forecasting volatility and potential downside in 2027 despite the 2026 upgrades. The company recently met Q4 earnings expectations with $0.22 EPS and exceeded revenue estimates, but still shows a negative net margin.
AMN Healthcare Services, Inc. (NYSE:AMN) Q4 2025 earnings call transcript
This document is an earnings call transcript for AMN Healthcare Services, Inc. (NYSE:AMN) for the fourth quarter of 2025. It details the discussions held during the company's investor call regarding its financial performance and outlook.
Zacks Research Analysts Increase Earnings Estimates for AMN
Zacks Research has increased its FY2027 EPS estimate for AMN Healthcare Services (NYSE:AMN) from $1.30 to $1.36 and projects an FY2028 EPS of $1.47, while maintaining a "Hold" rating. Several other firms have also adjusted price targets, leading to a MarketBeat consensus "Hold" rating with an average target price of $22.64. AMN recently matched its EPS consensus at $0.22 and exceeded revenue expectations at $748.2 million, despite reporting a negative net margin.
Should You Consider Purchasing AMN Healthcare Services (AMN) Following a Golden Cross?
AMN Healthcare Services (AMN) has experienced a "golden cross" pattern, where its 50-day simple moving average surpassed its 200-day moving average, signaling a potential bullish trend. The stock has risen 19.2% in the last month and holds a Zacks Rank #3 (Hold). Positive earnings revisions from analysts further support a favorable outlook for AMN, making it a stock investors might consider monitoring for potential gains.
Should You Consider Purchasing AMN Healthcare Services (AMN) Following a Golden Cross?
AMN Healthcare Services (AMN) has recently experienced a "golden cross," where its 50-day moving average surpassed its 200-day moving average, signaling a potential bullish trend. This technical indicator, combined with positive earnings outlooks and recent stock surges, suggests AMN could be an attractive investment. Analysts have made upward revisions for the current quarter, reinforcing the positive sentiment.
AMN Healthcare Services Inc (NYSE:AMN) Given Average Rating of "Hold" by Analysts
AMN Healthcare Services Inc (NYSE:AMN) has received an average "Hold" rating from nine brokerages, with an average 12-month price target of $22.64. The company recently reported Q4 EPS of $0.22, in line with estimates, and revenue of $748.23 million, exceeding expectations. Despite posting a negative net margin and P/E ratio, institutional investors hold a significant stake in the company.
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know
Several healthcare stocks, including AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals, experienced significant drops after a surprising February jobs report indicated a contraction in employment, particularly in the healthcare sector. The report showed a loss of 92,000 nonfarm payroll jobs and a 28,000 job reduction in healthcare, raising concerns about an economic slowdown and reduced healthcare spending. Evolent Health, in particular, has seen considerable volatility and is down 18.6% year-to-date, trading significantly below its 52-week high.
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know
Several healthcare stocks, including AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals, experienced significant drops after a disappointing February jobs report showed an unexpected contraction in nonfarm payrolls and substantial job losses in the healthcare sector. This data has raised concerns about a potential economic slowdown and reduced healthcare spending, impacting investor confidence in the sector. Evolent Health, in particular, has seen high volatility, with its shares significantly down since the beginning of the year.
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know
Several healthcare and pharmaceutical stocks, including AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals, experienced significant declines following a disappointing February jobs report. The report indicated an unexpected contraction in employment, particularly in the healthcare sector, raising concerns about a potential economic slowdown and reduced healthcare spending. Evolent Health, in particular, showed high volatility and a substantial year-to-date drop, further highlighting investor anxieties.
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know
Several healthcare and pharmaceutical stocks, including AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals, saw significant declines after a February jobs report indicated an unexpected contraction in employment, particularly in the healthcare sector. This news raised concerns among investors about a potential economic slowdown and reduced healthcare spending. Evolent Health, which experienced a 6.9% drop, had also been affected recently by a hot wholesale inflation report that fueled investor concerns about persistent price pressures.
(AMN) and the Role of Price-Sensitive Allocations
This article, published on Stock Traders Daily, analyzes Amn Healthcare Services Inc (NYSE: AMN) with a focus on price-sensitive allocations. It highlights strong near and mid-term sentiment but a weak long-term outlook, identifying elevated downside risk. The analysis provides AI-generated trading strategies including position trading, momentum breakout, and risk hedging strategies, complete with entry zones, targets, and stop losses.
AMN SEC Filings - Amn Healthcare 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for investors to access AMN Healthcare Services, Inc. (AMN) SEC filings, including 10-K, 10-Q, 8-K forms, and insider trading reports. It details the company's financial condition, governance, and significant events, enhanced with AI-powered summaries for easier understanding. Recent filings include insider transactions, debt refinancing, and amendments to its credit agreement.
AMN: Strike Staffing Strength And Industry Stabilization Will Shape A Measured Recovery
Analyst price targets for AMN Healthcare Services have increased to $22.21, driven by the company's strong large-scale labor disruption staffing capabilities and anticipated strike-related revenue. While bullish analysts highlight AMN's differentiation and signs of industry stabilization, bearish or neutral perspectives express caution regarding the sustainability of strike-related revenue and potential execution risks due to reliance on a few large contracts. Valuation adjustments include a higher fair value, slightly lower discount rate, and a more positive revenue growth outlook.
AMN Healthcare Services (NYSE:AMN) Share Price Passes Above Two Hundred Day Moving Average - What's Next?
AMN Healthcare Services (NYSE:AMN) shares have crossed above their 200-day moving average, trading at $20.97 after hitting a high of $21.46. The company recently reported earnings per share that met estimates and revenue that surpassed expectations, though it still has a negative net margin. Analyst ratings are mixed, with a consensus "Hold" rating and a target price of $22.64, but some firms have raised their price targets.
AMN Healthcare Survey Reveals Sharp Divide Between Leaders’ Organizational Confidence and Industry Outlook for 2026
A new AMN Healthcare survey highlights a significant confidence gap among healthcare executives: while most are optimistic about their own organizations' future in 2026, over half expect the broader healthcare industry to worsen. The report also notes a surge in demand for AI leadership skills, contrasting with persistent weaknesses in succession planning and clinician engagement. These findings underscore the need for adaptable leadership, particularly those adept at integrating AI and technology for improved access, quality, and operational performance.
Why healthcare leaders feel ready for 2026 but fear the industry’s future
A new survey by AMN Healthcare reveals a significant divide in confidence among healthcare executives for 2026: while nearly three-quarters are optimistic about their own organizations, over half fear a worse year for the broader industry. The survey highlights a surging demand for AI-savvy leaders, with 63% prioritizing AI strategy, yet also points to persistent challenges in succession planning, clinician engagement, and leadership recruitment. These findings suggest that adaptability and investment in strong leadership, especially in AI, will be crucial for success in the coming year.
AMN Healthcare Survey Reveals Sharp Divide Between Leaders’ Organizational Confidence and Industry Outlook for 2026
A new AMN Healthcare survey indicates a growing confidence gap among healthcare executives, with nearly three-quarters optimistic about their own organizations' strength in 2026, while over half anticipate a worse year for the industry overall. The survey also highlights a significant rise in demand for AI-savvy leaders, alongside persistent challenges in succession planning and clinician engagement. These findings suggest that successful healthcare organizations in the coming year will be those that invest in strong, adaptable leadership capable of integrating AI and technology for improved access, quality, and operational performance.
AMN Healthcare Services (NYSE:AMN) Given New $24.00 Price Target at Citizens Jmp
Citizens Jmp has increased its price target for AMN Healthcare Services (NYSE:AMN) to $24.00 from $22.00, maintaining a "market outperform" rating and suggesting a 23.37% upside for the stock. Despite a mixed analyst consensus of "Hold" with an average price target of $22.64, AMN recently beat revenue estimates with $748.23 million and met EPS expectations at $0.22, though it reported a negative net margin of -3.51%. The company's stock currently trades around $19.45 with a market capitalization of approximately $747 million.
AMN Healthcare Services (NYSE:AMN) Trading Up 5.3% on Analyst Upgrade
AMN Healthcare Services (NYSE: AMN) saw its stock price jump 5.3% after Citizens Jmp raised its price target from $22 to $24, maintaining an "outperform" rating. Other analysts, including JPMorgan Chase & Co. and BMO Capital Markets, have also set price targets of $25. Despite mixed analyst sentiment, with a MarketBeat consensus of "Hold" and a $22.64 target, institutional investors have increased their holdings, and the company recently reported in-line EPS and revenue that beat estimates for the last quarter.
Citizens raises AMN Healthcare stock price target on strike response By Investing.com
Citizens has raised its price target for AMN Healthcare Services Inc. (AMN) to $24 from $22, maintaining a Market Outperform rating, due to the company's strong capability in providing labor disruption services. The firm believes AMN deserves more credit for this differentiated service, viewing normalized growth potentially resuming in 2027. Despite previous impacts from strikes, Citizens sees a high probability of AMN retaining its Kaiser contract, which accounts for 22% of its 2025 revenue.
Citizens raises AMN Healthcare stock price target on strike response By Investing.com
Citizens increased its price target for AMN Healthcare Services Inc. (NYSE:AMN) to $24 from $22, maintaining a Market Outperform rating, due to the company's strong capability in providing labor disruption services. The firm believes AMN deserves more recognition for this differentiated service, especially given the potential for industry stabilization and AMN's strong relationship with Kaiser, which accounts for 22% of its 2025 revenue. The new target reflects a revised 2027 EBITDA estimate and suggests a 24% upside from its current trading price.
Citizens raises AMN Healthcare stock price target on strike response
Citizens has raised its price target on AMN Healthcare Services Inc. (NYSE:AMN) to $24 from $22, maintaining a Market Outperform rating. This increase is attributed to AMN's strong capability in providing labor disruption services, which Citizens now views as a differentiated strength. The firm also noted potential industry stabilization by 2027 and a high probability of AMN retaining its crucial Kaiser contract.
5 Questions with Matt Kozlov, Managing Director of Techstars Space
Matt Kozlov, Managing Director of Techstars Space, discusses his focus on next-generation space technology companies, adjacent industries seeking aerospace go-to-market channels, and technologies applicable to space. He emphasizes the importance of resilient teams, the transformative power of government engagement, and his passion for the rapidly evolving space sector. Kozlov also highlights the "Give First" philosophy, which he applies by connecting founders with essential resources and helping them navigate challenges.
AMN Healthcare Services (AMN) Q4 Earnings Match Estimates
AMN Healthcare Services (AMN) reported Q4 earnings of $0.22 per share, matching Zacks Consensus Estimates, but a significant decline from $0.75 a year ago. Revenue for the quarter was $748.23 million, surpassing estimates. Despite outperforming the market year-to-date, the stock currently holds a Zacks Rank #4 (Sell) due to unfavorable estimate revisions, suggesting potential underperformance in the near future.
AMN Healthcare Services (AMN) Shares Skyrocket, What You Need To Know
AMN Healthcare Services (AMN) shares jumped significantly after reporting fourth-quarter sales that exceeded analyst estimates and providing a strong revenue forecast for the upcoming quarter. Despite an earnings miss, investors focused on the positive outlook. The company's stock has seen volatility but is up 17% year-to-date, though still below its 52-week high.
UPDATE – AMN Healthcare Announces Fourth Quarter and Full Year 2025 Results
AMN Healthcare Services, Inc. announced its fourth quarter and full year 2025 financial results, with quarterly revenue of $748 million and an adjusted EPS of $0.22, exceeding expectations due to strong performance in nurse and allied staffing. The company reported a full-year revenue of $2.730 billion, a decrease of 8% from the prior year, and reduced its debt by $285 million in 2025 while also providing a positive outlook for the first quarter of 2026.
